This Review provides an updated approach to the diagnosis of idiopathic pulmonary fibrosis
(IPF), based on a systematic search of the medical literature and the expert opinion of …

Although these conditions are rare, a proportion of patients with interstitial lung diseases
(ILDs) may develop a progressive-fibrosing phenotype. Progressive fibrosis is associated …

Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It
represents a collaborative effort among the American Thoracic Society, Japanese …

Background The purpose of this analysis is to provide evidence-based and consensus-
derived guidance for clinicians to improve individual diagnostic decision-making for …

Awareness of hypersensitivity pneumonitis (HP) as a unique disease entity dates back to the
18th century (1). Since then, numerous inciting agents have been attributed to inducing HP …

Background: In 2002 the American Thoracic Society/European Respiratory Society
(ATS/ERS) classification of idiopathic interstitial pneumonias (IIPs) defined seven specific …

Coronavirus disease 2019 (COVID-19), a recently emerged lower respiratory tract illness,
has quickly become a pandemic. The purpose of this review is to discuss and differentiate …

Background Diffuse parenchymal lung disease represents a diverse and challenging group
of pulmonary disorders. A consistent diagnostic approach to diffuse parenchymal lung …

This document is an international evidence-based guideline on the diagnosis and
management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American …

Hypersensitivity pneumonitis (HP) is a complex syndrome caused by the inhalation of a
variety of antigens in susceptible and sensitized individuals. These antigens are found in the …